Zobrazeno 1 - 10
of 20
pro vyhledávání: '"N. Arger"'
Publikováno v:
B102. ADVANCES IN MEDICAL EDUCATION IN PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Curr Opin Pulm Med
PURPOSE OF THE REVIEW: Sarcoidosis is a systemic disease characterized by granulomatous inflammation of unknown etiology. There is extensive heterogeneity between patients with respect to the number and types of organs involved, disease course, and r
Publikováno v:
TP5. TP005 INTERSTITIAL LUNG DISEASE PATHOGENESIS.
Publikováno v:
Respir Med
BACKGROUND: Sarcoidosis is a systemic granulomatous disease of unknown etiology that affects the lungs in 90% of patients, but has a wide range of disease manifestations and outcomes including chronic and progressive courses. Noninvasive biomarkers a
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Background: Interferon-gamma (IFN-γ) is a key mediator of sarcoidosis-related granulomatous inflammation. Previous findings of IFN-γ-producing Th17 cells in bronchoalveolar lavage fluid from sarcoidosis patients invokes the transition of Th17.0 cel
Publikováno v:
B35. SARCOIDOSIS CLINICAL AND MECHANISTIC STUDIES.
Publikováno v:
B35. SARCOIDOSIS CLINICAL AND MECHANISTIC STUDIES.
Autor:
Pennan M. Barry, Alexander W. Kay, Peter Chin-Hong, Martin Cilnis, Matthew J. Kuehnert, Neha Shah, Pallavi Annambhotla, Louise McNitt, Tambi Shaw, Carol Greene, N. Arger, Nikole Neidlinger, Sridhar V. Basavaraju
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report
In the spring of 2015, a local health department (LHD) in county A notified the California Department of Public Health (CDPH) about three adults with close ties to one another and a congregate community site who had received diagnoses of tuberculosis
Publikováno v:
Respir Med
Background Sarcoidosis is a granulomatous inflammatory disease with limited blood markers to predict outcomes. The interferon-gamma (IFN-γ)-inducible chemotactic cytokines (chemokines), CXCL9 and CXCL10, are both increased in sarcoidosis patients, y